BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Masnata M, Salem S, de Rus Jacquet A, Anwer M, Cicchetti F. Targeting Tau to Treat Clinical Features of Huntington's Disease. Front Neurol 2020;11:580732. [PMID: 33329322 DOI: 10.3389/fneur.2020.580732] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Salem S, Cicchetti F. Untangling the Role of Tau in Huntington's Disease Pathology. J Huntingtons Dis 2023. [PMID: 36806513 DOI: 10.3233/JHD-220557] [Reference Citation Analysis]
2 Alpaugh M, Masnata M, de Rus Jacquet A, Lepinay E, Denis HL, Saint-pierre M, Davies P, Planel E, Cicchetti F. Passive immunization against phosphorylated tau improves features of Huntington's disease pathology. Molecular Therapy 2022;30:1500-22. [DOI: 10.1016/j.ymthe.2022.01.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Schor NF, Bianchi DW. Neurodevelopmental Clues to Neurodegeneration. Pediatr Neurol 2021;123:67-76. [PMID: 34399111 DOI: 10.1016/j.pediatrneurol.2021.07.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Dent P, Booth L, Roberts JL, Poklepovic A, Cridebring D, Reiman EM. Inhibition of heat shock proteins increases autophagosome formation, and reduces the expression of APP, Tau, SOD1 G93A and TDP-43. Aging (Albany NY) 2021;13:17097-117. [PMID: 34252884 DOI: 10.18632/aging.203297] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
5 D'Mello SR. When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer's and Huntington's Disease. Int J Mol Sci 2021;22:5911. [PMID: 34072862 DOI: 10.3390/ijms22115911] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
6 Lopes de Andrade V, Marreilha Dos Santos AP, Aschner M. NEUROTOXICITY OF METAL MIXTURES. Adv Neurotoxicol 2021;5:329-64. [PMID: 34263093 DOI: 10.1016/bs.ant.2020.12.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]